AXGN Stock Analysis: Buy, Sell, or Hold?
AXGN - Axogen, Inc. Common Stock
$44.95
0.11 (0.25%)
▲
5d:
+4.53%
30d:
+5.29%
90d:
+46.04%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When AXGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AXGN shows positive signals but monitor for confirmation. Market pricing in 3.4% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: AXGN shows positive signals but monitor for confirmation. Market pricing in 3.4% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.46
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.02
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXGN is currently trading at $44.95, which is considered extended relative to its 30-day fair value range of $40.14 to $42.93. From a valuation perspective, the stock is trading at a premium (Forward PE: 61.7) compared to its historical average (55.8). At these levels, the market is pricing in 3.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $45.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AXGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $50.78 (+13.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $45.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AXGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $50.78 (+13.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$40.14 -
$42.93
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($50.78)
- NEUTRAL: Market pricing in 3.4% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$40.14 -
$42.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$40.33
Resistance Level
$45.83
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
61.72
Wall Street Target
$50.78
(+13.0%)
Revenue Growth (YoY)
26.6%
Profit Margin
-13.2%
Valuation Premium vs History
+3.4% premium
PE vs Historical
61.7 vs 55.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.4%
(market-implied from PE analysis)
1-Year Target
$46.48
(+3%)
2-Year Target
$48.06
(+7%)
3-Year Target
$49.69
(+11%)
3-Yr Target (if PE normalizes)
(PE: 62→56)
PE COMPRESSION
$44.93
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 61.7, Growth: 49.1%)
$148.87
(+231%)
Base:
(SPY PE: 21.8, Growth: 49.1%)
$52.53
(+17%)
Bear:
(PE: 18.5, Growth: 49.1%)
$44.65
(-1%)
Share & Embed Analysis
Last updated: June 23, 2026 6:12 AM ET
Data refreshes hourly during market hours. Next update: 7:12 AM
Data refreshes hourly during market hours. Next update: 7:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Erick Wayne Devinney
SELL
5221 shares
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
Advanced AXGN Option Strategies
Professional options setups generated by AI based on today's AXGN price and gamma walls.
